Study identifies strategy to avoid resistance to cancer therapy

Resistance to therapies is one of the obstacles to overcome in cancer treatments. Understanding the mechanisms of this resistance is essential to design strategies that favor tumor cell death. A study led by the Protein Kinases and Cancer group of the Vall d’Hebron Research Institute (VHIR), the Department of Biochemistry and Molecular Biology and the Institute of Neurosciences of the Universitat Autònoma de Barcelona (UAB) has deciphered a new mechanism to sensitize cancer cells to a specific therapy that so far has not been effective because of tumor resistance.